Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
NQO-1 Antibody, Novus Biologicals™

Rabbit Polyclonal Antibody
Supplier: Novus Biologicals NBP131355
Description
NQO-1 Polyclonal specifically detects NQO-1 in Human, Mouse, Rat, Monkey samples. It is validated for Western Blot, Immunohistochemistry, Immunocytochemistry/Immunofluorescence, Immunohistochemistry-Paraffin.Specifications
NQO-1 | |
Polyclonal | |
Unconjugated | |
PBS, 20% Glycerol (pH7) with 0.025% Proclin 300 | |
NQO1 | |
Carrier-protein conjugated synthetic peptide encompassing a sequence within the C-terminus region of human NQO1. The exact sequence is proprietary. | |
Affinity Purified | |
RUO | |
Primary | |
Predicted cross-reactivity based on sequence identity: Rhesus Monkey (100%) and Bovine (83%). Not yet tested in any other species. | |
Aliquot and store at -20C or -80C. Avoid freeze-thaw cycles. |
Western Blot, Immunohistochemistry, Immunocytochemistry, Immunofluorescence, Immunohistochemistry (Paraffin) | |
1.0mg/mL | |
Western Blot 1:500-1:3000, Immunohistochemistry 1:100-1:1000, Immunocytochemistry/Immunofluorescence 1:100-1:1000, Immunohistochemistry-Paraffin 1:100-1:1000, KnockDown Validated | |
Azoreductase, DHQU, DIA4azoreductase, diaphorase (NADH/NADPH) (cytochrome b-5 reductase), dioxin-inducible 1, DTDEC 1.6.5.2, DT-diaphorase, Menadione reductase, NAD(P)H dehydrogenase [quinone] 1, NAD(P)H dehydrogenase, quinone 1, NAD(P)H:menadione oxidoreductase 1, NAD(P)H:Quinone acceptor oxidoreductase type 1, NAD(P)H:quinone oxidoreductase 1, NAD(P)H:quinone oxireductase, NMOR1diaphorase-4, Phylloquinone reductase, QR1NMORI, Quinone reductase 1 | |
Rabbit | |
31 kDa | |
100 μL | |
Cancer, Cellular Markers | |
1728 | |
Human, Mouse, Rat, Monkey | |
IgG |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
For Research Use Only
Spot an opportunity for improvement?Share a Content Correction